We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 27 of 347 for:    scleroderma

Hands on - a Hand Care Guide in Systemic Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02610842
Recruitment Status : Unknown
Verified November 2015 by Eduardo de Paiva Magalhães, University of Campinas, Brazil.
Recruitment status was:  Active, not recruiting
First Posted : November 20, 2015
Last Update Posted : December 18, 2015
Information provided by (Responsible Party):
Eduardo de Paiva Magalhães, University of Campinas, Brazil

Brief Summary:
Hands are commonly affected in Systemic Sclerosis (SS). The objective of this research is to apply a home based hand care guide in patients with SS and to evaluate its response regarding hand pain, function, strength and mobility.

Condition or disease Intervention/treatment
Scleroderma Other: Handbook

Detailed Description:

Introduction: Hands are commonly affected in Systemic sclerosis (SS). Skin thickening, Raynaud phenomenon, digital ulcers and cutaneous calcinosis may result in pain, disability and claw deformity. Strategies to improve hand function are recommended since its diagnosis and throughout the treatment. Unfortunately hand care assistance is not often available. The objective of this study was to developed a brief guide about hand care and home-based exercises to be applied in our outpatient clinic.

Methods: A brief program , with instructions about the disease and home-based exercises will be applied in a group patients with Systemic Sclerosis (SS) during the period of 12 weeks. Hand function (Cochin Hand and Functional Scale), disability (HAQ-Scleroderma), quality of life (SF-36 hand pain (visual analogue scale), grip and pinch strength, hand mobility (delta finger) will be assessed in the first appointment and after twelve weeks.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Hands on - a Hand Care Guide in Systemic Sclerosis
Study Start Date : January 2015
Primary Completion Date : October 2015
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Scleroderma
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Handbook group
Patients will receive a home based program named "Hands on" - a hand care guide in Systemic Sclerosis" which includes a handbook with instructions about the disease and hand exercises. Patients will be asked to follow the program instructions and carry out the exercises daily during the following 12 weeks.
Other: Handbook
The handbook named "Hands on" - a hand care guide in Systemic Sclerosis" contains instructions about the Systemic Sclerosis and hand exercises.

Primary Outcome Measures :
  1. Cochin Hand Functional Scale [ Time Frame: 12 weeks ]

    The purpose of this self-report scale is to measure functional ability in the hand.

    The questions ask how much difficulty the person has performing 18 tasks without the help of any assistive device. Kitchen tasks include holding a bowl and a plate full of food, pouring liquid, cutting meat, and peeling fruit. The dressing items include buttoning and opening/closing a zipper. The hygiene items include squeezing a tube of toothpaste and holding a toothbrush. Office items include 2 writing tasks, while other items include turning a doorknob, cutting with scissors, and turning a key in a lock. Score range is from 0-90. A higher score indicates greater disability or more difficulty, whereas a lower score indicates less disability or difficulty.

  2. Visual analogue pain scale [ Time Frame: 12 weeks ]

Secondary Outcome Measures :
  1. Delta finger-to-palm [ Time Frame: 12 weeks ]
    The standard finger-to-palm (FTP) measurement is obtained using a ruler to measure the distance (in centimetres)between the tip of the pulp on the 3rd finger and the distal palmar crease while the patient attempts to make a full fist (maximal finger flexion at all 3 finger joints: MCP, PIP, and DIP). The delta FTP is finger extension, the distance between the 3rd fingertip and the distal palmar crease while the patient attempts full finger extension, minus the FTP.

  2. The Short Form (36) Health Survey [ Time Frame: 12 weeks ]
    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

  3. Scleroderma Health Assessment Questionnaire [ Time Frame: 12 weeks ]
    The HAQ DI is a self-reported questionnaire in 8 domains.The SHAQ consists of the HAQ (8 domains) and also includes the following scales: pain, patient global assessment, vascular, digital ulcers, lung involvement, and gastrointestinal involvement.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of Systemic Scleroderma according to the American College of Rheumatology (Criteria Committee, Arthritis Rheum. 2013).
  • Involvement of hands with skin thickening.
  • Interest in participating in the investigation
  • Ability to read and to answer the the proposed questionnaires

Exclusion Criteria:

  • Upper limb commitment due other reasons other than Systemic Sclerosis.
  • Presence of digital ulcers, hand deformities or conditins that impede the realization of the proposed exercises
  • Clinical manifestations that impede the performance of the proposed exercises

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02610842

Clinical Hospital of University of Campinas
Campinas, São Paulo, Brazil, 13083-888
University of Campinas
Campinas, São Paulo, Brazil, 13603027
Sponsors and Collaborators
University of Campinas, Brazil
Study Director: Bertolo B Manoel, MD,PhD University of Campinas

Responsible Party: Eduardo de Paiva Magalhães, MD, PhD, University of Campinas, Brazil
ClinicalTrials.gov Identifier: NCT02610842     History of Changes
Other Study ID Numbers: UOP01
First Posted: November 20, 2015    Key Record Dates
Last Update Posted: December 18, 2015
Last Verified: November 2015

Additional relevant MeSH terms:
Scleroderma, Systemic
Scleroderma, Diffuse
Pathologic Processes
Connective Tissue Diseases
Skin Diseases